GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 3.674
AS - Asia 1.965
EU - Europa 1.006
SA - Sud America 345
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 47
OC - Oceania 16
Totale 7.188
Nazione #
US - Stati Uniti d'America 3.537
SG - Singapore 794
IT - Italia 415
CN - Cina 313
BR - Brasile 267
VN - Vietnam 252
HK - Hong Kong 176
DE - Germania 160
BD - Bangladesh 89
GB - Regno Unito 79
IN - India 70
ID - Indonesia 65
JP - Giappone 65
CA - Canada 63
FR - Francia 49
MX - Messico 44
FI - Finlandia 43
NL - Olanda 43
PL - Polonia 43
RU - Federazione Russa 39
AR - Argentina 36
TR - Turchia 21
SE - Svezia 19
ES - Italia 18
ZA - Sudafrica 17
AU - Australia 16
IQ - Iraq 16
AT - Austria 15
AE - Emirati Arabi Uniti 12
CO - Colombia 12
UA - Ucraina 12
PK - Pakistan 11
EC - Ecuador 10
MY - Malesia 10
CR - Costa Rica 9
SA - Arabia Saudita 9
PH - Filippine 8
RO - Romania 8
CH - Svizzera 7
IE - Irlanda 7
LT - Lituania 7
MA - Marocco 7
CZ - Repubblica Ceca 6
EG - Egitto 6
TH - Thailandia 6
VE - Venezuela 6
DK - Danimarca 5
GR - Grecia 5
JM - Giamaica 5
KR - Corea 5
BE - Belgio 4
HU - Ungheria 4
IL - Israele 4
NG - Nigeria 4
UY - Uruguay 4
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KE - Kenya 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GD - Grenada 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
Totale 7.040
Città #
Singapore 497
Ashburn 465
San Jose 322
Council Bluffs 188
Santa Clara 184
Hong Kong 171
Chandler 127
Dallas 122
New York 100
Beijing 99
Los Angeles 95
Ho Chi Minh City 87
Munich 85
Milan 68
Tokyo 61
Hanoi 60
Jakarta 53
Fairfield 45
Warsaw 42
Atlanta 39
Lauterbourg 36
Shanghai 35
São Paulo 34
Bologna 32
Ferrara 32
Rome 31
Toronto 31
Houston 30
Mexico City 28
Chicago 27
London 24
San Francisco 24
Addison 23
Denver 23
Buffalo 22
Bremen 21
Chennai 21
Princeton 21
Phoenix 20
Helsinki 18
Orem 18
Hefei 17
The Dalles 17
Brooklyn 15
Seattle 15
Cambridge 14
Turku 14
Amsterdam 12
Frankfurt am Main 12
Manchester 12
Montreal 12
San Diego 12
Wilmington 12
Modena 11
Boston 10
Stockholm 10
Da Nang 9
Haiphong 9
Lappeenranta 9
Naples 9
New Delhi 9
Rio de Janeiro 9
Sydney 9
Woodbridge 9
Falkenstein 8
Florence 8
Kuala Lumpur 8
Moscow 8
Poplar 8
Salt Lake City 8
San José 8
Ann Arbor 7
Boardman 7
Casalecchio Di Reno 7
Charlotte 7
Hải Dương 7
Mumbai 7
Portland 7
Ankara 6
Baghdad 6
Newark 6
Ottawa 6
Washington 6
Brasília 5
Buenos Aires 5
Columbus 5
Guarulhos 5
Hillsboro 5
Johannesburg 5
Miami 5
Nuremberg 5
Paris 5
Raleigh 5
Thái Nguyên 5
Turin 5
Vienna 5
Assago 4
Bangkok 4
Barnet 4
Brno 4
Totale 3.944
Nome #
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 1.093
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 221
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 215
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 205
A tool to predict survival in stage IV entero-pancreatic NEN 201
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 197
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 186
Functional hypothalamic and drug-induced amenorrhea: an overview 184
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 183
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 172
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 172
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 166
Acromegaly in the elderly patients 165
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 162
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 158
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 156
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 155
Craniopharyngioma and Eating Disorders 153
Bone health in adolescence 147
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 147
Long-term low-dose tolvaptan efficacy and safety in SIADH 145
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 144
Iperprolattinemia: vecchie e nuove insidie diagnostiche 144
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 140
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 139
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 135
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 135
Hypeprolactinemia: still an insidious diagnosis 128
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 128
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 125
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study 120
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 119
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 113
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 111
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 99
I livelli di colesterolo LDL sono associati alla secrezione insulinica 98
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 95
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 95
L’acromegalia nell’anziano 93
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 86
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 84
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 79
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 69
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) [Neuroendocrine Neoplasms prognostic markers] 66
Acromegalia: differenze di sesso e genere [Sex and gender differences in acromegaly] 60
Totale 7.188
Categoria #
all - tutte 35.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 901
Totale 36.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022153 0 0 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024314 12 24 15 10 16 47 13 27 26 15 15 94
2024/20251.264 43 50 96 52 138 138 60 54 217 118 162 136
2025/20263.636 348 131 319 418 554 226 408 229 298 407 177 121
2026/20271.370 761 461 148 0 0 0 0 0 0 0 0 0
Totale 7.188